MARIA DEL CARMEN DIAZ CORTE-rekin lankidetzan egindako argitalpenak (17)

2021

  1. Defining a Methylation Signature Associated With Operational Tolerance in Kidney Transplant Recipients

    Frontiers in Immunology, Vol. 12

  2. The APOB polymorphism rs1801701 A/G (p.R3638Q) is an independent risk factor for early-onset coronary artery disease: Data from a Spanish cohort

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 31, Núm. 5, pp. 1564-1568

2019

  1. A subset of low density granulocytes is associated with vascular calcification in chronic kidney disease patients

    Scientific Reports, Vol. 9, Núm. 1

  2. Effect of Type of Dialysis on CMV-Specific CD8+ T Cells in Kidney Transplant Candidates

    Frontiers in immunology, Vol. 10, pp. 1680

2018

  1. Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and their association with type 2 diabetes and impaired renal function

    Human Immunology, Vol. 79, Núm. 6, pp. 494-498

2017

  1. Phenotypic characteristics of aged CD4+ CD28null T lymphocytes are determined by changes in the whole-genome DNA methylation pattern

    Aging Cell, Vol. 16, Núm. 2, pp. 293-303

2015

  1. A 3′-UTR polymorphism in soluble epoxide hydrolase gene is associated with acute rejection in renal transplant recipients

    PLoS ONE, Vol. 10, Núm. 7

  2. ABCB1 (MDR-1) pharmacogenetics of tacrolimus in renal transplanted patients: A Next Generation Sequencing approach

    Clinical Chemistry and Laboratory Medicine, Vol. 53, Núm. 10, pp. 1515-1519

  3. Association between the IL17RA rs4819554 polymorphism and reduced renal filtration rate in the Spanish RENASTUR cohort

    Human Immunology, Vol. 76, Núm. 2-3, pp. 75-78

  4. The donor ABCB1 (MDR-1) C3435T polymorphism is a determinant of the graft glomerular filtration rate among tacrolimus treated kidney transplanted patients

    Journal of Human Genetics, Vol. 60, Núm. 5, pp. 273-276

2014

  1. Soluble co-signaling molecules predict long-term graft outcome in kidney-transplanted patients

    PLoS ONE, Vol. 9, Núm. 12

2013

  1. A search for new CYP3A4 variants as determinants of tacrolimus dose requirements in renal-transplanted patients

    Pharmacogenetics and Genomics, Vol. 23, Núm. 8, pp. 445-448

2012

  1. Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus

    Molecular Genetics and Metabolism, Vol. 105, Núm. 3, pp. 525-527

2011

  1. Erratum: Pharmacogenetics of tacrolimus after renal transplantation: Analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes (Clinical Chemistry and Laboratory Medicine (2011) 49:5 (825-833))

    Clinical Chemistry and Laboratory Medicine

  2. KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients

    Clinical Transplantation, Vol. 25, Núm. 3

  3. Pharmacogenetics of tacrolimus after renal transplantation: Analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes

    Clinical Chemistry and Laboratory Medicine, Vol. 49, Núm. 5, pp. 825-833

  4. Pharmacogenetics of tacrolimus: Ready for clinical translation

    Kidney International Supplements, Vol. 1, Núm. 2, pp. 58-62